Global Lactase Market size is projected to reach approximately USD 321.9 Million by 2027, at a CAGR of 6.7% from 2020 to 2027. Lactase is an enzyme that catalyzes the breakdown of lactose into simple sugars: glucose and galactose. It is added to dairy products or supplements to break down the lactose and make it easier for the consumers to digest. The demand for lactase is gaining huge importance among dairy manufacturers owing to the rising demand for lactose-free products. The high prevalence of lactose intolerance among the population worldwide has increased the demand for lactose-free products. Thus, dairy manufacturers are highly inclined towards increasing their product line of lactose-free products. This has encouraged the lactase manufacturers for new product launches. For instance, in November 2020, DSM launched its new Maxilact Super lactase enzyme to produce lactose-free and sugar-reduced dairy products. With the outbreak of COVID-19, the population worldwide are becoming conscious of their diet intake and are highly inclined towards supplements. This has triggered the growth of lactase among the manufacturers of dietary supplements in the long run.
Many consumers are dependent on dairy as an important source of protein and nutrients. However, around 70% of the global population are unable to tolerate lactose, a type of sugar that is naturally present in milk. Thus, the lactose-free category is growing significantly, with numerous new product launches worldwide, in all dairy applications. The main focus is on milk and yogurt, but it is expanding rapidly to other dairy products such as cheese, sour cream, and milk powder. Also, there is an increasing demand for lactase supplements available in various forms and consumption, which may reduce or prevent many of the symptoms that can occur when someone with lactose intolerance consumes dairy. Moreover, continuous R&D on various sources to extract lactase creates several growth opportunities for the lactase market. However, rising demand for dairy alternatives acts as a restraint for the market growth.
Rising prevalence of lactose-intolerance
|Market Size||USD 321.9 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||By Source, By Application and By Region|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Hansen Holding A/S (Denmark), Kerry Inc. (Ireland), Koninklijke DSM N.V. (Netherlands), Novozymes (Denmark), Merck KGaA (Sigma-Aldrich) (Germany), DuPont (US), Senson (Finland), Amano Enzyme Inc. (Japan), Advanced Enzyme Technologies (India), Enmex (Mexico), Nature BioScience Pvt. Ltd (India), Aumgene Biosciences (India), Creative Enzymes (US), Biolaxi Corporation (India), Novact Corporation (US)|
|Key Market Opportunities||Rising demand for lactose-free products|
|Key Market Drivers||